These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25893131)

  • 21. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
    Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
    Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
    Ugwu DI; Okoro UC; Ukoha PO; Okafor S; Ibezim A; Kumar NM
    Eur J Med Chem; 2017 Jul; 135():349-369. PubMed ID: 28460310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
    Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
    J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triazole derivatives and their antiplasmodial and antimalarial activities.
    Chu XM; Wang C; Wang WL; Liang LL; Liu W; Gong KK; Sun KL
    Eur J Med Chem; 2019 Mar; 166():206-223. PubMed ID: 30711831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.
    Wattanakul T; Teerapong P; Plewes K; Newton PN; Chierakul W; Silamut K; Chotivanich K; Ruengweerayut R; White NJ; Dondorp AM; Tarning J
    Malar J; 2016 Apr; 15():244. PubMed ID: 27118212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
    Rudrapal M; Chetia D; Singh V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, risk factors, and antimalarial resistance patterns of falciparum plasmodiasis among pregnant women in Kaduna metropolis, Nigeria.
    Aliyu MM; Nasir IA; Umar YA; Vanstawa AP; Medugu JT; Emeribe AU; Amadu DO
    Ci Ji Yi Xue Za Zhi; 2017; 29(2):98-103. PubMed ID: 28757774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria.
    Karbwang J; Na-Bangchang K
    Fundam Clin Pharmacol; 1994; 8(6):491-502. PubMed ID: 7721226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives.
    Korotchenko V; Sathunuru R; Gerena L; Caridha D; Li Q; Kreishman-Deitrick M; Smith PL; Lin AJ
    J Med Chem; 2015 Apr; 58(8):3411-31. PubMed ID: 25654185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro.
    Mishra N; Arora P; Kumar B; Mishra LC; Bhattacharya A; Awasthi SK; Bhasin VK
    Eur J Med Chem; 2008 Jul; 43(7):1530-5. PubMed ID: 17977622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
    Renner UD; Oertel R; Kirch W
    Ther Drug Monit; 2005 Oct; 27(5):655-65. PubMed ID: 16175141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput analysis of standardized pharmacokinetic studies in the rat using sample pooling and UPLC-MS/MS.
    Bueters T; Dahlström J; Kvalvågnaes K; Betnér I; Briem S
    J Pharm Biomed Anal; 2011 Jul; 55(5):1120-6. PubMed ID: 21530131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J
    J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.
    Cobbold SA; McConville MJ
    Methods Mol Biol; 2019; 1859():225-239. PubMed ID: 30421232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.